How to buy Chembio Diagnostics shares | 11 March price $4.82

How to buy Chembio Diagnostics shares | $4.82

Own Chembio Diagnostics shares in just a few minutes. Share price changes are updated daily.

Chembio Diagnostics, Inc (CEMI) is a leading diagnostics and research business based in the US. It opened the day at $4.75 after a previous close of $4.7. During the day the price has varied from a low of $4.67 to a high of $4.85. The latest price was $4.82 (25 minute delay). Chembio Diagnostics is listed on the NASDAQ and employs 355 staff. All prices are listed in US Dollars.

How to buy shares in Chembio Diagnostics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: CEMI in this case.
  5. Research Chembio Diagnostics shares. The platform should provide the latest information available.
  6. Buy your Chembio Diagnostics shares. It's that simple.
The whole process can take as little as 15 minutes.

Chembio Diagnostics share price

Use our graph to track the performance of CEMI stocks over time.

Chembio Diagnostics shares at a glance

Information last updated 2021-03-11.
Open$4.75
High$4.85
Low$4.67
Close$4.82
Previous close$4.7
Change $0.12
Change % 2.5532%
Volume 217,958
Information last updated 2021-04-14.
52-week range$3.01 - $15.89
50-day moving average $4.4583
200-day moving average $5.2888
Wall St. target price$9
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.73
Promoted
eToro Free Stocks

Invest in Chembio Diagnostics shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Fees for buying 100x Chembio Diagnostics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Fineco logo £0 No minimum £6.30
£351.27 total
Capital at risk
eToro Free Stocks logo £0 $200 £1.72
£346.69 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £1.06
£346.03 total
Capital at risk
Stake logo £0 £50 £2.01
£346.98 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £15.69
£360.65 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £13.45
£358.42 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £14.10
£359.07 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy Chembio Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Chembio Diagnostics price performance over time

Historical closes compared with the last close of $4.82

1 week (2021-04-09) 17.85%
1 month (2021-03-19) 15.31%
3 months (2021-01-20) -23.97%
6 months (2020-10-20) -1.83%
1 year (2020-04-20) -65.67%
2 years (2019-04-18) -31.63%
3 years (2018-04-20) -38.99%
5 years (2016-04-20) -33.24%

Financials

Revenue TTM $32.5 million
Gross profit TTM $-912,784
Return on assets TTM -22.75%
Return on equity TTM -98.52%
Profit margin -78.6%
Book value $1.376
Market capitalisation $78.2 million

TTM: trailing 12 months

How to short and sell Chembio Diagnostics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "CEMI.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 2.0 million Chembio Diagnostics shares held short by investors – that's known as the "short interest". This figure is 0.1% down from 2.0 million last month.

There are a few different ways that this level of interest in shorting Chembio Diagnostics shares can be evaluated.

Short interest ratio (SIR)

Chembio Diagnostics's "short interest ratio" (SIR) is the quantity of Chembio Diagnostics shares currently shorted divided by the average quantity of Chembio Diagnostics shares traded daily (recently around 800848.17813765). Chembio Diagnostics's SIR currently stands at 2.47. In other words for every 100,000 Chembio Diagnostics shares traded daily on the market, roughly 2470 shares are currently held short.

However Chembio Diagnostics's short interest can also be evaluated against the total number of Chembio Diagnostics shares, or, against the total number of tradable Chembio Diagnostics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chembio Diagnostics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Chembio Diagnostics shares in existence, roughly 100 shares are currently held short) or 0.0998% of the tradable shares (for every 100,000 tradable Chembio Diagnostics shares, roughly 100 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chembio Diagnostics.

Find out more about how you can short Chembio Diagnostics stock.

Chembio Diagnostics share dividends

We're not expecting Chembio Diagnostics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have Chembio Diagnostics's shares ever split?

Chembio Diagnostics's shares were split on a 1:8 basis on 29 May 2012. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Chembio Diagnostics shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Chembio Diagnostics shares which in turn could have impacted Chembio Diagnostics's share price.

Share price volatility

Over the last 12 months, Chembio Diagnostics's shares have ranged in value from as little as $3.01 up to $15.89. A popular way to gauge a stock's volatility is its "beta".

CEMI.US volatility(beta: 1.83)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chembio Diagnostics's is 1.8312. This would suggest that Chembio Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site